Myovant Sciences, Ltd. IPO Research Information

Myovant Sciences, Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Myovant Sciences, Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Myovant Sciences, Ltd.	MYOV - NYSE	$12.00-$15.00	$15.00	$15.00	14.5 million	10/27/2016
Underwriter(s): Citigroup, Cowen and Company, Evercore ISI, Barclays
Co-Manager(s): JMP Securities, Baird
Industry: Health Care
Filing(s): Filed 2016-09-30 Terms Added 2016-10-17

Myovant Sciences, Ltd. Quote & Chart - Click for current quote - MYOV

About Myovant Sciences, Ltd. (adapted from Myovant Sciences, Ltd. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MYOV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.